Journal of International Psychiatry

Objective To discuss the clinical effect of haloperidol combined with psychotherapy in children with tic disorder. Methods Eighty cases of pediatric patients with tic disorder from February 2016 to August 2019 were selected as the research objects and randomly divided into two groups. The control group was treated with haloperidol, and the observation group developed psychological treatment based on this drug for 8 weeks. The Yale syndrome severity scale (YGTSS) and the childrens self-awareness scale (PHCSS) were evaluated before and after treatment, and the comprehensive efficacy was compared between the two groups with reference to the YGTSS score improvement rate. Results After treatment, the PHCSS scores in both groups were significantly reduced, and the PHCSS scores were significantly increased. After treatment, the PHCSS scores in the observation group were significantly lower than those in the control group, and the PHCSS scores were significantly higher than those in the control group. The differences were statistically significant (P <0.05); The total effective rate of treatment in the group was significantly higher than that in the control group, and the difference was statistically significant (P <0.05); there was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusion Haloperidol can achieve better clinical effects in treating tic disorders in children. Psychotherapy based on this drug treatment can help children improve their self-awareness and reduce the severity of tics.

Haloperidol; Psychological Care; Psychological Treatment; Tics in Children